Uncovering and Addressing Implicit Bias in Oncology.

Implicit bias affects patient care every day, and not just in oncology. It impacts decision-making in already vulnerable populations such as the historically marginalized racial and ethnic groups, the LGBTQI+ population, patients with disabilities, and patients with low socioeconomic status or low health literacy. At JADPRO Live 2022 in Aurora, Colorado, panelists took a deep look at implicit bias and its impact on health inequities. They then discussed best practices for increasing equity and representation in clinical trials, ways to facilitate equitable communication and interactions with patients, and finally shared steps that advanced practitioners can take to minimize the impact of implicit bias.

Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?

The data show that racial and ethnic minority groups throughout the United States experience higher rates of illness and death across a wide range of health conditions when compared to their White counterparts. This session at JADPRO Live Virtual 2021 explained race, social determinants of health, and the impact of health disparities on oncology patients, highlighting concrete ways advanced practitioners can reduce health disparities and improve patient outcomes.